Download PDF
Nervenheilkunde 2005; 24(08): 702-708
DOI: 10.1055/s-0038-1630002
Deutsche Gesellschaft für Muskelkranke e.V.
Schattauer GmbH

Diagnostik bei Myalgien

Bundeseinheitliche Konsensuspapiere der Neuromuskulären Zentren im Auftrag der Deutschen Gesellschaft für Muskelkranke e.V. (DGM)Myalgias diagnosticsconsensus statement of the German Centers for Neuromuscular Disease
C. Berghoff
1   Neurologische Klinik der Universität Erlangen-Nürnberg
,
A. Bayas
2   Neurologische Klinik der Universität Würzburg
,
R. Gold
3   Institut für MS-Forschung, Bereich Humanmedizin der Universität Göttingen und Gemeinnützige Hertie-Stiftung
,
C. Sommer
2   Neurologische Klinik der Universität Würzburg
,
D. Pongratz
4   Friedrich-Baur-Institut München
,
D. Heuss
1   Neurologische Klinik der Universität Erlangen-Nürnberg
› Author Affiliations
Further Information

Publication History

Eingegangen am: 30 October 2004

angenommen am: 31 October 2004

Publication Date:
31 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Lokalisierte oder generalisierte Schmerzen der Skelettmuskulatur sind häufige Leit- oder Begleitsymptome von Erkrankungen aus verschiedenen medizinischen Fachdisziplinen. Die ätiologische Abklärung von Myalgien erfolgt anhand des Beschwerdebildes, des klinischen Untersuchungsbefundes und gegebenenfalls weiterführender Untersuchungen. Die vorliegende Arbeit stellt alle derzeitigen diagnostischen Möglichkeiten vor sowie einen Algorithmus für die zielgerichtete Diagnostik bei Myalgien.

Summary

Localized or generalized muscle pain is a common symptom associated with a variety of neurological and other diseases. The etiologic differentiation of myalgias is based on history and clinical findings and may include further diagnostic investigations. Here we present current diagnostic possibilities including an algorithm for an efficient approach to the diagnosis of myalgias.

Schlüsselwörter

Myalgie - Muskelschmerz - Diagnostik

Keywords

Myalgia - muscle pain - diagnostic investigation
 

  • Literatur

  • 1 Späth M. Aktuelles zu Diagnostik und Therapie bei Myalgien ohne definierte Myopathie. Nervenheilkunde 2002; 21: 29-34.
    Google Scholar
  • 2 Gempel K. et al. Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis 2002; 25: 17-27.
    CrossrefGoogle Scholar
  • 3 Kaufman LD, Krupp LB. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1995; 7: 560-7.
    CrossrefGoogle Scholar
  • 4 Sieb JP, Gillessen T. Iatrogenic and toxic myopathies. Muscle Nerve 2003; 27: 142-56.
    CrossrefGoogle Scholar
  • 5 Pongratz D, Müller-Felber W. Muskelschmerzen. Internist (Berl) 1990; 31: 41-50.
    Google Scholar
  • 6 Mense S. Neurobiologische Grundlagen von Muskelschmerz. Schmerz 1999; 13: 3-17.
    CrossrefGoogle Scholar
  • 7 Franz M, Mense S. Muscle receptors with group IV afferent fibres responding to application of bradykinin. Brain Res 1975; 92: 369-83.
    CrossrefGoogle Scholar
  • 8 Babenko V. et al. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain 1999; 82: 1-8.
    CrossrefGoogle Scholar
  • 9 Ernberg M. et al. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci 1999; 65: 313-25.
    CrossrefGoogle Scholar
  • 10 Issberner U, Reeh PW, Stehen KH. Pain due to tissue acidosis: a mechanism for inflammatory and ischemic myalgia?. Neurosci Let 1996; 208: 191-4.
    CrossrefGoogle Scholar
  • 11 Hedenberg-Magnusson B. et al. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand 2001; 59: 348-55.
    CrossrefGoogle Scholar
  • 12 Schäfers M, Sorkin LS, Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 2003; 104: 579-88.
    CrossrefGoogle Scholar
  • 13 Pongratz D, Späth M. Fibromyalgie. Fortschr Neurol Psychiatr 2001; 69: 189-93.
    Article in Thieme ConnectGoogle Scholar
  • 14 Vaerøy H. et al. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988; 32: 21-6.
    CrossrefGoogle Scholar
  • 15 Russell IJ. et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593-601.
    CrossrefGoogle Scholar
  • 16 Maes M. et al. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 1999; 24: 371-83.
    CrossrefGoogle Scholar
  • 17 Wallace DJ. et al. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 2001; 40: 743-9.
    CrossrefGoogle Scholar
  • 18 Gur A. et al. Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002; 20: 753-60.
    Google Scholar
  • 19 Salemi S. et al. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 2003; 30: 146-50.
    Google Scholar
  • 20 Bayas A, Gold R. Diagnostische Prinzipien bei Muskelerkrankungen. Fortschr Neurol Psychiatr 2003; 71: 61-6.
    Article in Thieme ConnectGoogle Scholar
  • 21 Timpl P. et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998; 19: 162-6.
    CrossrefGoogle Scholar
  • 22 Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-99.
    CrossrefPubMedGoogle Scholar
  • 23 Stein C, Mendl G. The German counterpart to McGill Pain Questionnaire. Pain 1988; 32: 251-5.
    CrossrefGoogle Scholar
  • 24 George A. et al. Musculosceletal pain in myotonic dystrophy type 2. Arch Neurol 2004; 61: 1938-42.
    Google Scholar
  • 25 Bohner J. et al. Stability of macro creatine kinases and creatine kinase isoenzymes compared: heat inactivation test for determination of thermostable creatine kinases. J Clin Chem Clin Biochem 1981; 19: 1021-6.
    Google Scholar
  • 26 Pointner H. Enzymaktivitäten im Plasma. In: Laboratoriumsdiagnostik. G.G.; Deutsch E, Wenger R. (Ed). Medizinisch wissenschaftliche Buchreihe von Schering. 1992: 781-3.
    Google Scholar
  • 27 Lindner A, Zierz S. Rhabdomyolyse und Myoglobinurie. Nervenarzt 2003; 74: 505-15.
    CrossrefGoogle Scholar
  • 28 Lindner A. et al. Acute compartment syndrome after forearm ischemic work test in a patient with McArdle’s disease. Neurology 2001; 56: 1779-80.
    CrossrefGoogle Scholar
  • 29 Hogrel JY. et al. A non-ischemic forearm exercise test for the screening of patients with exercise intolerance. Neurology 2001; 56: 1733-8.
    CrossrefGoogle Scholar
  • 30 Kazemi-Esfarjani P. et al. A non-ischemic forearm exercise test for McArdle disease. Ann Neurol 2002; 52: 153-9.
    CrossrefGoogle Scholar
  • 31 Heuss D. Muskelschmerzen. Nervenheilkunde 1998; 17: 201-6.
    Google Scholar
  • 32 Heuss D, Claus D, Neundörfer B. Fibrillations in regenerating muscle in dystrophic myopathies. Clin Neuropathol 1996; 15: 200-8.
    Google Scholar
  • 33 Lofberg M. et al. Antimyosin scintigraphy compared with magnetic resonance imaging in inflammatory myopathies. Arch Neurol 1998; 55: 987-93.
    CrossrefGoogle Scholar
  • 34 Reimers CD, Kele H. Muskelsonographie bei neuromuskulären Erkrankungen. Orthopäde 2002; 31: 165-71.
    CrossrefGoogle Scholar
  • 35 Mastaglia FL. et al. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27: 407-25.
    CrossrefPubMedGoogle Scholar
  • 36 Park JH, Olsen NJ. Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies. Curr Rheumatol Rep 2001; 3: 334-45.
    CrossrefGoogle Scholar
  • 37 Beggs AH. et al. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990; 86: 45-8.
    PubMedGoogle Scholar
  • 38 Mendell JR. et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology 2001; 57: 645-50.
    CrossrefGoogle Scholar
  • 39 Niiyama T. et al. Diagnosis of dystrophinopathy by skin biopsy. Muscle Nerve 2002; 25: 398-401.
    CrossrefGoogle Scholar
  • 40 Mills KR, Edwards RH. Investigative strategies for muscle pain. J Neurol Sci 1983; 58: 73-8.
    CrossrefGoogle Scholar